Skip to main content
. 2023 Jul 19;146(3):433–450. doi: 10.1007/s00401-023-02599-5

Table 1.

Demographics of post-mortem samples used in this study

Number of subjects Sex Age of onset (years ± SD) Age at death (years ± SD) Disease duration (years ± SD)
Control 12 6 F: 6 M n/a 77.08 ± 11.96 n/a
C9-ALS 10 5 F: 5 M 53.22 ± 8.47 57.10 ± 8.46 2.59 ± 1.73
C9-ALS/FTD 6 3 F: 3 M 65.17 ± 7.49 67.17 ± 6.31 1.89 ± 0.98
C9-FTD 9 4 F: 5 M 58.56 ± 4.75 66.22 ± 5.05 7.67 ± 2.06